COVID-19 hospitalisation, mortality, vaccination, and postvaccination trends among people with schizophrenia in Israel: a longitudinal cohort study

This article details a year-long, longitudinal cohort study of individuals with schizophrenia to examine COVID-19 hospitalization, mortality, vaccination, and postvaccination infection rates. Results show that individuals with schizophrenia are at an increased risk of hospitalization and mortality and have lower rates of vaccination than the general population. Medical comorbidities also play a significant role in worsening outcomes and mortality for this sub-population.

Resource Details

• Population: People With a Mental Illness
• Setting/Context of Implementation: Community
• Topics of Practice: Data Collection and Analysis
• Outcomes of Interest: Reduction of Health Disparities
• Level of Evidence: Emerging
• Tools or Materials Included in Resource: No
• Social Determinants of Health: Healthcare Access and Quality
• Outside of US: No